Please assess the completion status of the following clinical trial:

Trial Title: Polyphenols and Insulin Resistance

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Absence of anti HIV or anti hepatitis C antibodies and of HBS antigen.~* Acceptable biological assessment of the hepatic and renal functions (γGT, ALAT, ASAT \< 3 times the normal value and serum creatinine \<150 micromol/l).~* Age between 30 and 55 years.~* Fasting plasma glucose \<110 mg/dl and absence of any anti-diabetic treatment~* No regular physical activity (Voorips index \< 9)~* Absence of any drug treatment in progress and during the last 2 months~* Subjects with at least one 1st degree relative with T2D and with a body mass index between 25 and 35 kg/m² and a waist measurement \>94 cm for males, and \>80 cm for females.~* Normal ionogram (sodium 135 - 145 mmol/l, potassium 3,5 - 4,5 mmol/l).~* Normal ferritin level (75 - 300 ng/ml)~* hs-CRP \<8 mg/l.~* Absence of arterial hypertension (systolic pressure \<140 mmHg and diastolic pressure \<90 mmHg).~* Non smoker or former smoker (quit smoking \>1 year).~* Alcohol consumption \<30 g/day.~Exclusion Criteria:~* Hyperthermia (T°\>38°c)~* Subject deprived of freedom by a court or administrative order~* Major protected by the law~* Subject who is in a period of relative exclusion due to his/her participation to another protocol or for whom the annual maximum amount of allowances of 3 811.23 € is reached.~* Subject who has been treated with anti-coagulants, anti-inflammatory drugs, b-blockers or insulin during the last month.~* Subject who cannot be subjected to muscle biopsy.~* Allergy to the anaesthetic~* Woman in age to procreate and not taking any oral or intra-uterine contraception

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Study Arms:
- Polyphenols (Type: EXPERIMENTAL): 9 weeks of supplementation with polyphenols(D56) and during the last week supplementation with polyphenols associated with a fructose load during the last 6 days (D63).
- placebo (Type: PLACEBO_COMPARATOR): 9 weeks of supplementation with placebo (D56) and during the last week supplementation with placebo associated with a fructose load during the last 6 days (D63).

Based on this trial design, predict the completion outcome and termination type (if applicable).